Cargando…
Of chloroquine and COVID-19
Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with ch...
Autores principales: | Touret, Franck, de Lamballerie, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132364/ https://www.ncbi.nlm.nih.gov/pubmed/32147496 http://dx.doi.org/10.1016/j.antiviral.2020.104762 |
Ejemplares similares
-
Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment?
por: Uzun, Tuğçenur, et al.
Publicado: (2020) -
Pharmaceutical care of chloroquine phosphate in elderly patients with coronavirus pneumonia (COVID‐19)
por: Sun, Xuelin, et al.
Publicado: (2020) -
COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help
por: Lentini, Giovanni, et al.
Publicado: (2020) -
In vitro evaluation of therapeutic antibodies against a SARS-CoV-2 Omicron B.1.1.529 isolate
por: Touret, Franck, et al.
Publicado: (2022) -
Battling the malaria iceberg with chloroquine in India
por: Sharma, Vinod P
Publicado: (2007)